Trials / Completed
CompletedNCT07157085
AI Multitask Model for HCC Treatment
AI-Driven Multitask Model for Guiding Treatment Decision-Making in Hepatocellular Carcinoma
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 7,000 (actual)
- Sponsor
- Sun Yat-sen University · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
We will integrate multi-modal cardiac data via an AI multitask framework to develop and validate concurrent models for liver function, treatment prognosis, and microvascular invasion (MVI) prediction in hepatocellular carcinoma. The resulting tool will be prospectively deployed to guide personalized surgical, TACE, and systemic therapy decisions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Comprehensive treatment | Comprehensive HCC therapies include liver resection, TACE, HAIC, targeted therapy, immunotherapy and radiotherapy |
Timeline
- Start date
- 2008-01-01
- Primary completion
- 2023-12-31
- Completion
- 2023-12-31
- First posted
- 2025-09-05
- Last updated
- 2025-09-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT07157085. Inclusion in this directory is not an endorsement.